Gara Jalqabaatti › Dhibee Qara › Maryland › Baltimore
Qorannoo klinikaalii Dhibee Qara Baltimore, MD keessatti
Qorannoo 40 Dhibee Qara f Baltimore fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Namoota walitti qabaa jiraSadarkaa 3
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Namoota walitti qabaa jiraSadarkaa 3
- Greater Baltimore Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- fi 4 dabalataa
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Namoota walitti qabaa jiraSadarkaa 2
- MedStar Franklin Square Medical Center ( Site 0033), Baltimore
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- fi 2 dabalataa
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 2
- Johns Hopkins University, Baltimore
DK222 Study at Hopkins
Namoota walitti qabaa jiraSadarkaa 1
- Johns Hopkins Hospital, Baltimore
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Namoota walitti qabaa jiraSadarkaa 3
- Johns Hopkins University of Medicine, Baltimore
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Maryland Oncology Hematology, P.A., Annapolis · Miili 22 fagaatti
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 2
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Research Site, Baltimore
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Johns Hopkins, Baltimore
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Johns Hopkins Bayview Medical Center, Baltimore
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Saint Agnes Hospital - Baltimore - Hunt - PPDS, Baltimore
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 1
- University of Maryland Marlene & Stewart Greenebaum Comprehensive Cancer Center, Baltimore
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
Namoota walitti qabaa jiraSadarkaa 2
- MedStar Franklin Square Medical Center ( Site 0033), Baltimore
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Greater Baltimore Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Namoota walitti qabaa jiraSadarkaa 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Namoota walitti qabaa jiraQorannoo ilaalaa
- Johns Hopkins University, Baltimore
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- University of Maryland Baltimore Washington Medical Center, Glen Burnie · Miili 9 fagaatti
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Namoota walitti qabaa jiraSadarkaa 1/2
- Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
EXoPERT EMERALD Clinical Study
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- John Hopkins University, Baltimore
GCC 2546- Motion Management
Namoota walitti qabaa jira
- University of Maryland Greenebaum Cancer Center, Baltimore
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Kaiser Permanente-Woodlawn Medical Center, Baltimore
- Kaiser Permanente Lutherville - Timonium Medical Center, Lutherville · Miili 9 fagaatti
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Johns Hopkins University, Baltimore
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Johns Hopkins Hospital, Baltimore
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Namoota walitti qabaa jiraSadarkaa 1/2
- Johns Hopkins University, Baltimore
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2/3
- Saint Agnes Hospital, Baltimore
- Kaiser Permanente-Woodlawn Medical Center, Baltimore
- Kaiser Permanente Lutherville - Timonium Medical Center, Lutherville · Miili 9 fagaatti
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Kaiser Permanente-Woodlawn Medical Center, Baltimore
- Kaiser Permanente Lutherville - Timonium Medical Center, Lutherville · Miili 9 fagaatti
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2
- University of Maryland Medical Center, Baltimore
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Johns Hopkins University, Baltimore
Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore
- Harry and Jeannette Weinberg Cancer Institute at Franklin Square, Baltimore
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Namoota walitti qabaa jira
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Namoota walitti qabaa jiraSadarkaa 1
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens
Namoota walitti qabaa jiraQorannoo ilaalaa
- Johns Hopkins Hospital, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · Miili 8 fagaatti
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Namoota walitti qabaa jiraQorannoo ilaalaa
- Ascension St. Agnes Hospital, Baltimore
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Maryland Medical Center, Baltimore
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Qorannoo Dhibee Qara magaalota biroo keessatti
- Houston, TXQorannoo 78
- Boston, MAQorannoo 62
- New York City, NYQorannoo 60
- Los Angeles, CAQorannoo 45
- Arlington, VAQorannoo 41
- Washington, DCQorannoo 41
- Chicago, ILQorannoo 41
- Nashville, TNQorannoo 40
- St. Louis, MOQorannoo 39
- Columbus, OHQorannoo 37
- Philadelphia, PAQorannoo 36
- Seattle, WAQorannoo 33
Qorannoo biroo Baltimore keessatti
- Kansara Qara'a Non-Small CellQorannoo 60
- Saree OljooQorannoo 47
- Kansarii ProstateQorannoo 43
- Saree (Gosoota Hunda)Qorannoo 37
- Kansarii PancreasQorannoo 31
- Kansarii ColorectalQorannoo 31
- Kansara MetastatikiiQorannoo 28
- ObesityQorannoo 26
- Dukkana BladderQorannoo 24
- Cufama OnneeQorannoo 24
- Kansarii OvariiQorannoo 22
- StrokeQorannoo 21
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.